Eli Lilly Obesity Drug Poised To Blow Up Weight Loss Industry

Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.

As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.

Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or ha...

Subscribe to view this content.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at info@greatgameindia.com.